Gleevec Keeps a Leukemia in Check for More Than a Decade: Study

WEDNESDAY, March 8, 2017 — The cancer drug Gleevec appears to keep chronic myeloid leukemia at bay a decade into treatment — with no signs of additional safety risks, a new study finds.
Gleevec — known generically as imatinib — was hailed as a…
Source: Topamax